Coagulation factor VIII (Hebei Daan Pharma)

人凝血因子Ⅷ（博晖生物）

Report date: 2025/12/23 11:24:09

Base Information

Drug NameCoagulation factor VIII (Hebei Daan Pharma)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activationCoagulation factor VIII replacements
TargetsCoagulation factor XCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryMainland China
Original Approved Date2025/12/16
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHebei Daan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHebei Daan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A